Omni Bio Pharmaceutical, Inc, located in Denver, CO and referred to Vibato from Hein & Associates, is a small company in terms of overall employee size but is still an accelerated filer and will be subjected to the 404(b) requirements in their coming year-end audit.  Because of their unusual business size relative to their nearly $300M market cap, Omni was faced with the challenge of finding the right Sarbanes-Oxley service provider who would understand the needs of a company with a large market cap and small overall employee size:

"We didn't have a dedicated budget to complete our SOX compliance but as a small public company that was going to be an accelerated filer by our next year-end, we knew we had to figure something out quickly that would allow us to comply with the full SOX 404 requirements.  Vibato had a solution for us that cost less than $6,000, which was significantly less expensive than anything else we had seen in the market.  I would recommend them to anyone looking for a cost-effective and scalable solution."  Bob Ogden, CFO, Omni Bio Pharmaceutical, Inc.